NextCure
(NASDAQ) NXTC
NextCure Financials at a Glance
Market Cap
$8.06M
Revenue (TTM)
$0.00
Net Income (TTM)
-$54.66M
EPS (TTM)
-$19.07
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$2.07
Volume
214,874
Open
$2.41
Price
$2.07
Volume
214,874
Open
$2.41
Previous Close
$2.08
Daily Range
$2.00 - $2.50
52-Week Range
$2.00 - $15.74
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$2.07
Volume
214,874
Open
$2.41
Previous Close
$2.08
Daily Range
$2.00 - $2.50
52-Week Range
$2.00 - $15.74
Estimated Earnings Date
Jul 30, 2026
NXTC News
Is NextCure a Buy?
Here's Why NextCure Crashed Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NextCure
Industry
Biotechnology
Sector
Health CareEmployees
40
CEO
Michael S. Richman
Website
www.nextcure.comHeadquarters
Beltsville, MD 20705, US
NXTC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-132%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.06M
Shares Outstanding
3.61M
Volume
214.87K
Avg. Volume
76.12K
Financials (TTM)
Gross Profit
-$2.19M
Operating Income
-$57.62M
EBITDA
-$53.66M
Operating Cash Flow
-$49.61M
Capital Expenditure
$0.00
Free Cash Flow
-$49.61M
Cash & ST Invst.
$41.82M
Total Debt
$4.15M
NextCure Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$283.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.06M
N/A
Market Cap/Employee
$187.33K
N/A
Employees
43
N/A
Net Income
-$9.80M
+10.8%
EBITDA
-$9.51M
+7.8%
Quarterly Fundamentals
Total Cash
$29.74M
-46.8%
Total Debt
$3.88M
-21.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.88M
-21.0%
Short Term Debt
$0.00
N/A
Return on Assets
-1.44%
N/A
Return on Invested Capital
-1.80%
N/A
Free Cash Flow
-$13.36M
-2.8%
Operating Cash Flow
-$13.36M
-2.8%